Ridgeview Arlington Clinic | |
601 W Chandler St Arlington MN 55307-2127 | |
(507) 964-2271 | |
(507) 964-8490 |
Full Name | Ridgeview Arlington Clinic |
---|---|
Speciality | Clinic/Center |
Location | 601 W Chandler St, Arlington, Minnesota |
Authorized Official Name and Position | Michael Phelps (PRESIDENT/CEO) |
Authorized Official Contact | 9524422191 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Ridgeview Arlington Clinic 601 W Chandler St P.o. Box 620 Arlington MN 55307-2127 Ph: (507) 964-2271 | Ridgeview Arlington Clinic 601 W Chandler St Arlington MN 55307-2127 Ph: (507) 964-2271 |
NPI Number | 1023078904 |
---|---|
Provider Enumeration Date | 03/24/2006 |
Last Update Date | 04/20/2022 |
Medicare PECOS PAC ID | 3870722499 |
---|---|
Medicare Enrollment ID | O20140203000569 |
News Archive
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today reported its financial results and business highlights for the second quarter of 2010.
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced 52-week results from PALACE 1, the Company's first phase III study in psoriatic arthritis at the European Congress of Rheumatology annual meeting in Madrid, Spain.
Even as the opioid epidemic dominated national attention over the past decade, the rate of overdose deaths involving cocaine, methamphetamine and other stimulants tripled, a new study in veterans suggests.
Pregnant and lactating rats fed on a diet of hydrogenated fat during pregnancy and lactation had babies who were fatter than rats fed a normal diet, according to research published in Lipids in Health and Disease.
› Verified 6 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1023078904 | NPI | - | NPPES |
871403700 | Medicaid | MN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261QR1300X | Clinic/center - Rural Health | (Minnesota) | Primary |
News Archive
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today reported its financial results and business highlights for the second quarter of 2010.
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced 52-week results from PALACE 1, the Company's first phase III study in psoriatic arthritis at the European Congress of Rheumatology annual meeting in Madrid, Spain.
Even as the opioid epidemic dominated national attention over the past decade, the rate of overdose deaths involving cocaine, methamphetamine and other stimulants tripled, a new study in veterans suggests.
Pregnant and lactating rats fed on a diet of hydrogenated fat during pregnancy and lactation had babies who were fatter than rats fed a normal diet, according to research published in Lipids in Health and Disease.
› Verified 6 days ago